The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
A Missouri-based subsidiary of Mansfield’s Covidien, Mallinckrodt Inc., accused a pair of Italian life science firm Bracco SpA‘s American divisions of patent infringement, The Boston Globe reported.
Hazelwood, Mo.-based Mallinckrodt sued Bracco’s Lake Success, N.Y.-based E-Z-EM Inc. and Acist Medical Systems Inc. of Eden Prairie, Minn., in Delaware federal court for allegedly infringing its patent for a device used to inject chemicals into MRI patients.
By MassDevice
Salaries among top-level executives at Thermo Fisher Scientific rose across the board after the company posted a 31 percent increase to its bottom line.
The Waltham-based laboratory instruments maker said executives received an average base wage increase of about 4 percent in 2008, not including performance bonuses and stock awards.
CEO Marijn Dekkers pulled in the highest compensation, at a $1.1 million base salary and $1.8 million in incentives. He was also granted stock valued at around $15.5 million. Dekkers, 51, took the helm at Thermo Fisher in 2002.
The National Institutes of Health tapped a prominent Boston-area physician and businessman to sit on a board responsible for setting policy at the federal health research agencies.
James Thrall, radiologist-in-chief at Massachusetts General Hospital, was one of three people named to the board on April 3.
The advisory committee to the director at the NIH is a powerful position. The 20-person board reports directly to the secretary of the federal Health and Human Services Dept., as well as the NIH director on policy matters.
Pharma is sexy. Big drugs, big money, big news. In the life sciences arena, perhaps only biotech commands a higher political and public profile.
So it isn’t surprising that the medical device industry’s groundbreaking inclusion in Massachusetts’ new code of conduct garnered relatively little attention.
But the new rules governing industry payments to physicians — the so-called “gift ban” — include provisions aimed at curbing what some call undue and improper influence by medical device manufacturers.
The U.S. Navy is furious that the federal Food & Drug Administration repeatedly spiked clinical trials of Biopure Corp.‘s Hemopure blood substitute, according to an internal Navy report obtained by The Boston Globe.
The Navy wants to examine whether Hemopure can be used on the battlefield to treat combat injuries when blood transfusions aren’t available.
Bruker Group acquired a German subsidiary of Varian Medical Systems for an undisclosed amount.
Bruker, which has operations in Billerica, closed the deal April 1 for Accel Instruments GmbH, a division of Varian that makes research instruments and proton therapy devices.
Doctors in the United Kingdom successfully performed the first surgery using proprietary technology made by I-Therapeutix Inc.
The Waltham-based ophthalmology firm makes the I-Zip ocular bandage, a synthetic hydrogel composed mostly of water. It’s applied as a liquid, but morphs into a soft, protective barrier which then breaks down into tears when the therapy is complete.
The company has CE-Mark approval to market the product in the European Union and is awaiting regulatory clearance in the United States.
Amicas Inc. closed its $39 million buyout of Emageon Inc. after the Birmingham, Ala.-based medical imaging software firm settled a lawsuit with shareholders trying to block the deal.
Boston-based Amicas, which provides medical imaging software and services, said the deal, for which it paid $1.82 per share to Emageon stockholders, expands its footprint in the healthcare IT field and makes the company a leader in the imaging and information business with a combined 1,000 customers.
Charles River Laboratories International Inc. agreed to acquire Piedmont Research Center LLC from PPD Inc. for $46 million in cash.
Wilmington, N.C.-based PRC provides preclinical discovery services in oncology and other therapeutic areas.
The Wilmington, Mass.-based lab services provider said the deal, expected to close during the second quarter, expands its reach into the pharmaceutical and biotech oncology treatment sphere.
Haemonetics Corp. acquired Altivation Software for an undisclosed amount.
Chico, Calif.-based Altivation provides blood bank management software.
The Braintree blood management products maker said the deal complements its existing platforms and adds the ability to manage mobile blood drives. The company plans to roll Altivation into its Haemonetics Software Solutions business, but keep its operations in Chico.
Hologic Inc. lost an anti-trust case against Qiagen Gaithersburg Inc.
The Bedford women’s health product manufacturer’s lawsuit alleging that the Dutch diagnostics firm violated federal anti-trust laws was denied (PDF) by the U.S. Court of Appeals for the Federal Circuit.
In response to a patent infringement suit filed against Hologics’ Third Wave Technologies division by Qiagen (then known as Digene Corp.) in January 2007, Hologics filed the anti-trust suit.
